Active substances

Gilteritinib›

L01EX13 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Other protein kinase inhibitors

Indicated for: cancer

Ginkgo biloba›

N06DX02 Nervous system | Anti-dementia drugs | Other anti-dementia drugs

Indicated for: cognitive disorders; peripheral vascular disease

Ginkgo biloba + panax ginseng›

N06BXN3 Nervous system | Psychostimulants, agents used for adhd and nootropics | Other psychostimulants and nootropics

Indicated for: asthenia; mild memory and concentration complaints

Givosiran›

A16AX16 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Various alimentary tract and metabolism products

Indicated for: acute hepatic porphyria

Glasdegib›

L01XJ03 Antineoplastic and immunomodulating agents | Other antineoplastic agents | Hedgehog pathway inhibitors

Indicated for: cancer

Glatiramer acetate›

L03AX13 Antineoplastic and immunomodulating agents | Immunostimulants | Immunostimulants | Other immunostimulants

Indicated for: multiple sclerosis

Glecaprevir + pibrentasvir›

J05AP57 Antiinfectives for systemic use | Direct acting antivirals | Antivirals for treatment of HIV infections

Indicated for: chronic hepatitis C

Glibenclamide›

A10BB01 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas

Indicated for: type 2 diabetes mellitus

Glibenclamide + metformin›

A10BD02 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Combinations of oral blood glucose lowering drugs

Indicated for: type 2 diabetes mellitus

Gliclazide›

A10BB09 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas

Indicated for: type 2 diabetes mellitus

Glimepiride›

A10BB12 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas

Indicated for: type 2 diabetes mellitus

Glipizide›

A10BB07 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas

Indicated for: type 2 diabetes mellitus

Gliquidone›

A10BB08 Alimentary tract and metabolism | Blood glucose lowering drugs, excl. insulins | Sulfonylureas

Indicated for: type 2 diabetes mellitus

Glofitamab›

L01FX28 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Other monoclonal antibodies and antibody drug conjugates

Indicated for: hematologic malignancies

Glucagon›

H04AA01 Systemic hormonal preparations, excluding sex hormones and insulins | Glycogenolytic hormones

Indicated for: hypoglycemia

Glucarpidase›

V03AF09 Various | All other therapeutic products | All other therapeutic products | Detoxifying agents for antineoplastic treatment

Indicated for: methotrexate toxicity

Glucosamine›

M01AX05 Musculo-skeletal system | Antiinflammatory and antirheumatic products | Antiinflammatory and antirheumatic products, non-steroids | Other antiinflammatory and antirheumatic agents, non-steroids

Indicated for: osteoarthritis; degenerative joint disorders

Glucose›

B05BA03 Blood and blood forming organs | I.v. solutions | Solutions for parenteral nutrition

Indicated for: hypoglycemia

Glucose + sodium chloride + potassium chloride›

B05BB02 Blood and blood forming organs | I.v. solutions | Solutions affecting the electrolyte balance

Indicated for: rehydration; fluid and electrolyte imbalance

Glycerol›

A06AX01 Alimentary tract and metabolism | Drugs for constipation | Drugs for constipation | Other drugs for constipation

Indicated for: constipation

Glycerol phenylbutyrate›

A16AX09 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Various alimentary tract and metabolism products

Indicated for: urea cycle disorders

Glycerophosphate›

B05XA14 Blood and blood forming organs | I.v. solution additives | Electrolyte solutions

Indicated for: mineral deficiency; mineral supplementation

Glycopyronium + formoterol›

R03AL07 Respiratory system | Adrenergics, inhalants | Adrenergics in combination with anticholinergics incl. triple combinations with corticosteroids

Indicated for: chronic obstructive pulmonary disease

Glycopyrronium bromide›

R03BB06 Respiratory system | Other drugs for obstructive airway diseases, inhalants | Anticholinergics

Indicated for: chronic obstructive pulmonary disease

Glycopyrronium bromide + neostigmine methylsulfate›

A03AB02 Alimentary tract and metabolism | Drugs for functional gastrointestinal disorders | Drugs for functional gastrointestinal disorders | Synthetic anticholinergics, quaternary ammonium compounds

Indicated for: reversal of neuromuscular blockade

Glycosides from Senna›

A06AB06 Alimentary tract and metabolism | Drugs for constipation | Drugs for constipation | Contact laxatives

Indicated for: constipation

Goldenrod herb + orthosiphon leaf + restharrow root›

G04BXN1 Genito urinary system and sex hormones | Urologicals | Urologicals | Other urologicals

Indicated for: urinary tract flushing; mild urinary infections; urinary stones

Golimumab›

L04AB06 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Tumor necrosis factor alpha (tnf-alpha) inhibitors

Indicated for: autoimmune inflammatory diseases

Goserelin›

L02AE03 Antineoplastic and immunomodulating agents | Hormones and related agents | Gonadotropin releasing hormone analogues

Indicated for: prostate cancer; breast cancer; endometriosis

Granisetron›

A04AA02 Alimentary tract and metabolism | Antiemetics and antinauseants | Antiemetics and antinauseants | Serotonin (5ht3) antagonists

Indicated for: chemotherapy-induced nausea and vomiting